Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.

Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19.

Publication date: Jul 14, 2024

SARS-CoV-2 has triggered a pandemic and contributes to long-lasting morbidity. Several studies have investigated immediate cellular and humoral immune responses during acute infection. However, little is known about long-term effects of COVID-19 on the immune system. We performed a longitudinal investigation of cellular and humoral immune parameters in 106 non-vaccinated subjects ten weeks (10 w) and ten months (10 m) after their first SARS-CoV-2 infection. Peripheral blood immune cells were analyzed by multiparametric flow cytometry, serum cytokines were examined by multiplex technology. Antibodies specific for the Spike protein (S), the receptor-binding domain (RBD) and the nucleocapsid protein (NC) were determined. All parameters measured 10 w and 10 m after infection were compared with those of a matched, noninfected control group (n = 98). Whole blood flow cytometric analyses revealed that 10 m after COVID-19, convalescent patients compared to controls had reduced absolute granulocyte, monocyte, and lymphocyte counts, involving T, B, and NK cells, in particular CD3CD45RACD62LCD31 recent thymic emigrant T cells and non-class-switched CD19IgDCD27 memory B cells. Cellular changes were associated with a reversal from Th1- to Th2-dominated serum cytokine patterns. Strong declines of NC- and S-specific antibody levels were associated with younger age (by 10. 3 years, p 

Concepts Keywords
10m COVID‐19
Pandemic leukopenia
Th2 long‐term effect
Vaccinated recent thymic emigrants
SARS‐CoV‐2
specific antibody decline

Semantics

Type Source Name
disease MESH COVID-19
disease MESH morbidity
disease IDO acute infection
pathway REACTOME Immune System
disease VO vaccinated
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO blood
disease MESH infection
disease MESH leukopenia

Original Article

(Visited 1 times, 1 visits today)